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OBJECTIVES We sought to compare bubble contrast echocardiography and pulmonary angiography in
detecting pulmonary arteriovenous malformation (PAVM) in children with cavopulmonary
anastomosis (CPA), and to examine anatomic and physiologic variables associated with the
development of PAVM.
BACKGROUND Development of PAVM in patients with CPA may cause profound cyanosis. Pulmonary
arteriovenous malformation has been traditionally diagnosed by pulmonary angiography with
reported incidence of 20% to 25% in patients with CPA.
METHODS Fourteen patients (age 1.1 to 12.6 years) with any forms of CPA and normal pulmonary
venous drainage formed the study population. All patients underwent cardiac catheterization
and pulmonary angiography. Bubble contrast echocardiographic studies were performed with
injection of 10 ml of agitated saline solution into branch pulmonary arteries. Transthoracic
echocardiograms using an apical view were performed to assess the appearance of bubble
contrast in the systemic ventricles. We compared the results of pulmonary angiograms and
contrast echocardiograms, and findings of contrast echocardiograms between lungs with
hepatic venous blood flow and lungs without hepatic venous blood.
RESULTS Ten of the 14 patients (71%) had positive contrast echocardiographic studies, compared with
three (21%) detected by pulmonary angiograms (p 5 0.01). No difference was found in
pulmonary artery pressure, transpulmonary gradient or presence of heterotaxy syndrome
between patients with positive contrast echocardiographic studies and patients with negative
studies. However, patients with positive contrast echocardiograms tended to have lower
oxygen saturation (81%) and higher hemoglobin (16.4 g/dl) compared with patients with
negative studies (88% and 14.7 g/dl, p 5 0.10 and p 5 0.18 respectively). Patients with Glenn
shunt or unidirectional Fontan had higher incidence of PAVM (10/11) compared with
patients with classic or lateral tunnel Fontan (0/3, p 5 0.01). All 12 lungs with no perfusion
of hepatic venous blood had positive contrast echocardiographic studies. Lungs with no
hepatic venous blood flow were more likely to develop PAVM compared with lungs with
hepatic venous blood flow (12/12 and 3/16 respectively, p , 0.01).
CONCLUSIONS Bubble contrast echocardiography is more sensitive in detecting PAVM compared with
pulmonary angiography. The prevalence of PAVM in patients with CPA may be much
higher than what had been reported previously. Lungs with no hepatic venous blood flow are
more likely to develop PAVM than lungs with hepatic venous blood flow. (J Am Coll
Cardiol 1999;33:2052–8) © 1999 by the American College of Cardiology
Cavopulmonary anastomosis (CPA), in the form of superior
vena cava to pulmonary artery (classic or bidirectional Glenn
shunt), or Fontan operation (total cavopulmonary anasto-
mosis) and its modifications, remains a useful method of
palliation in selected patients with congenital heart disease
of univentricular physiology (1–3). The development of
pulmonary arteriovenous malformation (PAVM) in patients
with CPA is a known “late” complication and may result in
significant morbidity such as increasing cyanosis and in-
creased operative risk for cardiac or noncardiac surgeries (4).
Although the prevalence of PAVM in patients with CPA
has not been well documented, some series reported a
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prevalence up to 25% in patients with Glenn shunt (5–7).
Although the etiology for the development of PAVM
remains unknown, abnormal distribution of pulmonary
blood flow after Glenn shunt or Fontan procedure is
considered one of the contributing factors by many authors
(5,6). Recently, Srivastava et al. reported that PAVM after
CPA is related to the exclusion of hepatic venous blood
from pulmonary circulation (7). These findings, combined
with observations of PAVM in patients with cirrhotic liver
disease, have led to the hypothesis that lack of some “hepatic
factor(s)” may contribute to the development of PAVM in
patients with liver disease and some patients after CPA (8).
However, cases of PAVM developed in patients after
Fontan operation have also been reported (9,10).
Diagnosis of PAVM has been traditionally made by right
heart catheterization and pulmonary angiography (11). Use
of two-dimensional contrast echocardiography for diagnos-
ing PAVM has been reported by few case reports (12–14).
However, the true usefulness of this diagnostic modality for
PAVM has not been well evaluated. The goal of this study
is to use bubble contrast echocardiography to evaluate
PAVM in patients with CPA. Specifically, the objectives
are as follows: 1) to compare contrast echocardiography and
angiography in diagnosing PAVM; 2) to investigate the
prevalence of PAVM in patients with various forms of CPA
by contrast echocardiography, and 3) to examine the role of
hepatic venous blood in the development of PAVM in
patients with CPA by contrast echocardiography.
METHODS
Patients. The study protocol was approved by the Human
Subject Protection Committee of the University of California,
Los Angeles. Fourteen patients with any forms of CPA were
recruited in the study. Although previous studies have docu-
mented that normal individuals should have no bubble contrast
pass through pulmonary capillary bed and return to the heart in
contrast echocardiography (15,16), we recruited three patients
with normal pulmonary venous return and without CPA as the
internal control group. No patients had mucocutaneous telan-
giectasia or other stigmata of Osler-Weber-Rendu syndrome.
Contrast echocardiography. Transthoracic echocardio-
grams were performed using an Acuson 128XP/10SP
Model (Acuson, Mountain View, California). A 3-Hz,
4-Hz or 5-Hz transducer was used (depending on patient’s
size) to obtain an apical view of the heart. Contrast agent
was produced by agitating solutions manually to form
air-filled microbubbles. Two 10-ml syringes were joined by
a three-way stopcock. One syringe contained 10 ml of 0.9%
saline solution, and the other syringe contained 1 ml of air.
The saline solution was agitated by rapidly flushing the
solution back and forth between the two syringes through
the three-way stopcock 10 times or more. A mixture of air
and liquid was thereby generated. A side-hole or end-hole
balloon catheter was placed with the tip of the catheter in
the left or right pulmonary artery without wedging in small
branches. Then a rapid hand injection of the agitated saline
was performed. Simultaneous recording of the apical view
echocardiogram of the injection was performed to visualize
the presence of bubble contrast in the pulmonary venous
atrium and systemic ventricle. In a normal individual, after
injection of saline bubble contrast in the pulmonary arteries,
the echo contrast quality of the bubbles is lost in the passage
through the pulmonary capillary bed and therefore no
bubbles should be observed in the left heart (17,18). The
presence of bubble contrast in the pulmonary venous atrium
and systemic ventricle indicates lack of passage of agitated
saline solution through the pulmonary capillary bed, and is
therefore indicative of the presence of intrapulmonary arte-
riovenous shunting (Fig. 1).
Pulmonary angiography. All 14 patients underwent right
heart catheterization and pulmonary angiography as clini-
cally indicated. In patients with Fontan operation, the
pulmonary arteries were entered in an antegrade manner
through the femoral veins. In patients with Glenn shunt or
interrupted inferior vena cava with azygous continuation,
the right internal jugular veins were used for access to the
pulmonary arteries. The pulmonary artery pressures and
pulmonary capillary wedge pressures were recorded in all
patients before angiograms. Selective pulmonary angio-
grams were performed with a side-hole balloon catheter, or
end-hole balloon catheter with proximal balloon inflation.
Tips of the catheters were positioned in the branch pulmo-
nary arteries to ensure adequate filling of the contrast in the
selected arteries and to avoid wedging of the catheter in
small branches. Half to 1 ml/kg body weight of Omnipaque
350 (Nycomed, New Jersey) contrast solution was injected
to the selected branch pulmonary artery. The fluoroscopic
cameras were angled at straight posterior–anterior and
lateral positions to ensure adequate demonstration of the
entire hemithorax, especially the bases of the lungs. Cinean-
giograms were recorded for review. Angiographic findings
were examined by two board-certified pediatric cardiologists
to determine the presence of PAVM.
Statistical analysis. The 14 patients were divided into
groups according to types of CPA and sources of pulmonary
blood flow. We first compared the contrast echocardio-
graphic findings with angiographic findings of PAVM in all
patients. Measurements of cardiac catheterization, includ-
ing pulmonary artery pressure, transpulmonary gradient,
aortic saturation and hemoglobin were compared between
patients with positive contrast echocardiographic studies
and patients with negative studies. We then examined the
sources of pulmonary blood flow to the left and right lungs
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for each patient. In the second analysis, we used the “lung”
(right lung or left lung) as the unit of analysis. There were
28 lungs from 14 patients. Each lung was examined to
determine if its blood supply included hepatic venous blood.
Two groups of lungs were formed: a group with hepatic
venous blood to pulmonary circulation and a group without
hepatic venous blood to pulmonary circulation. Comparison
of contrast echocardiograms was made between these two
groups of lungs. Continuous variables were compared by
Student t test, and categorical variables were compared by
chi-square test or Fisher exact test. A p value of less than
0.05 was considered statistically significant. Statistical anal-
ysis was conducted using software package SPSS 7.0 for
Windows (SPSS, Chicago, Illinois).
RESULTS
Patient characteristics. Clinical characteristics of 14 pa-
tients are summarized in Table 1. The mean age of patients
was 7.5 years (range 1.1 to 12.6 years, median 9 years).
There were eight boys and six girls. Heterotaxy syndrome
was present in five patients. The interval between CPA and
time of study ranged from 1 month to 8.6 years, with a
mean of 4.2 years and median of 4.8 years. These 14
patients were categorized into five groups according to their
initial diagnoses and types of CPA. Group 1 consisted of
three patients (Patients 1 to 3) who had bidirectional Glenn
shunt and no additional source of pulmonary flow from the
ventricle(s) or from an aortopulmonary shunt. Group 2
consisted of two patients (Patients 4 and 5) who had
interrupted inferior vena cava with azygous continuation to
the superior vena cava. These two patients were status post
Kawashima modification of Fontan operation with hepatic
veins left to drain into the common atria (19). Group 3
consisted of two patients (Patients 6 and 7) who had
unidirectional Fontan operation (connecting superior vena
cava to left pulmonary artery and inferior vena cava to right
pulmonary artery) (20). Group 4 consisted of four patients
(Patients 8 to 11) who had bidirectional Glenn shunt and
had additional sources of pulmonary flow from the ventri-
cle(s) or an aortopulmonary shunt. Group 5 consisted of
three patients (Patients 12 to 14) who had classic or lateral
tunnel Fontan operation.
Contrast echocardiography and angiography. All three
control individuals had negative contrast echocardiographic
and angiographic studies for PAVM. Ten of the 14 patients
with CPA (71%) had positive contrast echocardiographic
studies, compared with three (21%) detected by pulmonary
angiograms. The difference in prevalence of PAVM be-
tween contrast echocardiographic and angiographic diag-
noses was statistically significant (p 5 0.01). Of patients
with and patients without PAVM detected by contrast
echocardiography, there was no statistical difference in
gender, presence of heterotaxy syndrome or interval between
CPA and study (3.8 6 2.7 and 5.1 6 2.7 years respectively,
p 5 0.45). Patients with classic or lateral tunnel Fontan
(group 5) had no PAVM found (0/3), in contrast to patients
with Glenn shunt, unidirectional Fontan or Kawashima
modification of Fontan (10/11, p 5 0.01). Patients with
PAVM detected by contrast echocardiograms tended to
have lower oxygen saturation (81%) and higher hemoglobin
(16.4 g/dl) compared with patients without PAVM (88%
and 14.7 g/dl, p 5 0.10 and p 5 0.18 respectively).
The three patients who had positive angiographic find-
ings of PAVM also had positive contrast echocardiograms.
Two patients with positive angiograms at the right lung also
had positive contrast echocardiograms from the right; one
patient with positive angiogram at the left lung also had
positive contrast echocardiogram from the left. The two
patients in Group 3 (unidirectional Fontan, Patients 6 and
7) both had positive bubble contrast return in selective left
pulmonary artery injections and negative studies in selective
right pulmonary artery injections.
The mean pulmonary artery pressure in 14 patients was
Figure 1. Apical view of transthoracic bubble contrast echocardio-
grams of a patient with bidirectional Glenn shunt and pulmonary
stenosis. Preferential streaming of superior vena cava flow to the
right pulmonary artery and main pulmonary artery flow to the left
pulmonary artery was seen in angiograms. (A) Selective injection of
bubble contrast to the left pulmonary artery showed no significant
bubble contrast return to the left atrium. (B) Selective injection of
bubble contrast to the right pulmonary artery showed bubble
contrast opacifying the left atrium.
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15.2 mm Hg (median 13.5). The mean transpulmonary
gradient was 5.1 mm Hg (median 5). No statistical differ-
ence in pulmonary artery pressure or transpulmonary gradi-
ent was found between patients with PAVM and patients
without PAVM.
Lungs with or without hepatic venous blood. Patients in
Group 1 and Group 2 had no hepatic venous blood flow to
either left or right lungs. Patients in Group 3 had hepatic
venous blood flow only to the right lungs but not to the left
lungs. Therefore, of 28 lungs from our 14 study subjects,
there was a total of 12 lungs with no hepatic venous blood
perfusion and 16 lungs with hepatic venous blood (Table 2,
asterisks). All 12 lungs with no hepatic venous blood
perfusion had positive contrast echocardiographic studies.
The difference in positive contrast echocardiograms be-
Table 1. Patient Characteristics
Patient
Age (yr)/
Gender Diagnosis Heterotaxy
Cavopulmonary
Anastomosis
CPA
Study
Group 1—Glenn shunt with no hepatic venous blood to pulmonary arteries
1 1.6/F {S,D,D}, DORV, pulmonary atresia, d-MGA,
LSVC to CS, interrupted IVC with
hemiazygous vein continuation to LSVC
Yes RSVC-RPA (bidirectional) 0.9
2 7.4/M {S,D,D}, d-TGA, VSD, LV hypoplasia, PS and
sub-PS
No SVC-RPA (bidirectional),
MPA ligation
2.7
3 1.1/M {S,D,D}, HLHS, s/p BAS, stenting of PDA No SVC-RPA (bidirectional),
Norwood procedure
0.1
Group 2—Kawashima modification of Fontan operation
4 9.3/M {A,D,D}, DORV, hypoplastic LV and mitral valve,
common atrium, d-MGA, bilateral SVC,
interrupted IVC with azygous continuation to
LSVC, s/p right and left MBTS
Yes RSVC-RPA, LSVC-LPA
(both bidirectional)
5.7
5 8.7/M {A,D,D}, dextrocardia, common atrium,
hypoplastic LV, interrupted IVC with azygous
continuation to RSVC, bilateral SVC, s/p
modified Norwood procedure
Yes RSVC-RPA, LSVC-LPA
(both bidirectional)
6.3
Group 3—unidirectional Fontan
6 9.9/M {S,D,D}, DORV, TGA, PS, sub-PS, s/p PAB and
Glenn shunt (SVC-RPA, bidirectional)
No Unidirectional Fontan
(IVC-RPA, SVC-LPA)
and PA ligation
4.9
7 9.4/F {S,L,L}, DILV, 1-TGA, s/p Damus-Kaye-Stansel
procedure, central shunt and Glenn shunt
(SVC-RPA, bidirectional)
No Unidirectional Fontan
(IVC-RPA, SVC-LPA)
and PA ligation
2.8
Group 4—Glenn shunt with hepatic venous blood to pulmonary arteries
8 10/F {S,D,D}, dextrocardia, complete AVC, d-TGA,
LV hypoplasia, PS, bilateral SVC, s/p right
MBTS
Yes LSVC-LPA
(bidirectional), ligation
of RSVC
4.6
9 2.4/F {S,L,L}, 1-TGA, DILV, ventricular inversion No SVC-RPA (bidirectional),
PAB
1.4
10 6.2/F {S,D,D}, dextrocardia, common atrium, SV,
d-TGA, PS, single LSVC
Yes LSVC-LPA (bidirectional) 5.3
11 9.9/M {S,D,D}, HLHS, s/p Norwood procedure with
right MBTS, atrial septectomy
No SVC-RPA (bidirectional),
right MBTS takedown,
central shunt to LPA
8.6
Group 5—Classic or modified Fontan
12 11.5/F {S,D,D}, DORV, unbalanced AVC, LV
hypoplasia, PS, PAPVR
No Lateral tunnel Fontan 6.1
13 12.6/M {S,D,D}, tricuspid atresia, pulmonary atresia, RV
hypoplasia, s/p right MBTS
No RA-MPA, right MBTS
takedown
7.5
14 5.4/M {S,L,L}, SV, mitral atresia, 1-TGA, s/p PAB and
Glenn shunt (SVC-RPA, bidirectional)
No Lateral tunnel Fontan 1.3
AVC 5 atrioventricular canal; BAS 5 balloon atrial septostomy; CPA study 5 time interval between cavopulmonary anastomosis and study (years); CS 5 coronary sinus;
DILV 5 double inlet left ventricle; DORV 5 double outlet right ventricle; HLHS 5 hypoplastic left heart syndrome; IVC 5 inferior vena cava; LPA 5 left pulmonary artery;
LSVC 5 left superior vena cava; LV 5 left ventricle; MBTS 5 modified Blalock-Taussig shunt; MGA 5 malposition of great arteries; MPA 5 main pulmonary artery; PA 5
pulmonary artery; PAB 5 pulmonary artery band; PAPVR 5 partial anomalous pulmonary venous return; PDA 5 patent ductus arteriosus; PS 5 pulmonary stenosis; RA 5
right atrium; RPA 5 right pulmonary artery; RSVC 5 right superior vena cava; RV 5 right ventricle; s/p 5 status post; SV 5 single ventricle; SVC 5 superior vena cava; TGA 5
transposition of great arteries; VSD 5 ventricular septal defect.
2055JACC Vol. 33, No. 7, 1999 Chang et al.
June 1999;2052–8 Pulmonary AV Malformation
tween 12 lungs in the “without hepatic venous blood” group
(12 of 12 or 100%) and 16 lungs in the “with hepatic venous
blood” group (3 of 16 or 19%) was statistically significant
(p , 0.01). Left lungs of Patients 8 and 9 and the right lung
of Patient 11 were “lungs with hepatic venous blood” that
had positive contrast echocardiograms. On reviewing angio-
grams, streaming of flow containing hepatic venous return
away from the left pulmonary artery in Patient 8 and right
pulmonary artery in Patient 11 was noted during injections
of contrast to the Glenn shunt.
DISCUSSION
Prevalence of PAVM in patients with CPA. Although
the exact prevalence of PAVM in patients with CPA
remains unknown, Kopf et al. reported increasing incidence
with time after CPA (3). They reported a prevalence of 31%
of patients with Glenn shunts (mean 6.8 years from Glenn
shunt). Other authors have described the development of
PAVM in 21% to 25% of patients with Glenn shunt (5,6).
These studies were based on angiographic diagnosis of
PAVM. In the present study, we used contrast echocardi-
ography and found a prevalence of 71% in patients with
various forms of CPA. The prevalence of PAVM in our
patients was 21% based on angiographic findings, which was
consistent with previous reports. We speculate that the
difference in prevalence of PAVM using contrast echocar-
diography in our patients might be due to the superior
sensitivity of contrast echocardiography to traditional an-
giograms. To our knowledge, this is the first study to
compare the findings of contrast echocardiography and
angiography in diagnosing PAVM in patients with CPA.
Further studies are needed to define the exact prevalence of
PAVM by contrast echocardiography in patients with CPA.
Contrast echocardiography versus angiography. Hand-
agitated saline solution has been proved to be safe and has
been applied to many clinical settings to provide contrast
during echocardiographic studies (21). Animal studies have
shown that the lungs are superb filters for air bubbles (15).
Although systematic evaluation of microbubbles as echocar-
diographic contrast is deficient, the incidence of false
positive studies (i.e., air bubbles traverse the lungs and
return to the left atrium) appears to be very low in lungs
with intact capillary beds. It has been shown that bubbles
will escape entrapment by the pulmonary capillary system
only when the lungs are severely overloaded with air (20 ml
of air or more) or when a balloon-tipped catheter is wedged
in a pulmonary artery branch (15,22). In the present study,
we injected less than 1 ml of air and avoided wedging
catheters in small branches of pulmonary arteries during
contrast injection. Therefore, we believe that it is unlikely
that the positive contrast echocardiographic studies in our
patients were falsely positive because of technical or meth-
odological problems.
In this study, we demonstrated the superiority of contrast
echocardiography to angiography in the sensitivity of de-
tecting intrapulmonary arteriovenous shunting in patients
with CPA. Although patients with positive contrast echo-
cardiograms tended to have lower arterial saturation and
higher hemoglobin level, this may be due to the fact that
three of the four patients with negative contrast echocar-
diograms were in Group 5 (classic or lateral tunnel Fontan).
We speculate that patients with positive contrast echocar-
diographic studies and negative angiograms represent a
group of patients who have intrapulmonary arteriovenous
shunting and are in the early stage of PAVM development.
This group of patients may develop angiographically appar-
ent PAVM over time and should be followed closely with
Table 2. Findings of Cardiac Catheterization and Bubble Contrast Echocardiography
Patient
Mean PAP
(mm Hg)
TPG
(mm Hg)
O2 Sat
(%)
Hb
(g/dl)
Contrast Study Angiography
Left Right Left Right
1 14 6 72 14.5 1* 1* 2 2
2 8 2 82 17 1* 1* 2 1
3 14 7 73 14 1* 1* 2 2
4 18 3 81 17.5 1* 1* 1 2
5 13 3 81 18.4 1* 1* 2 2
6 13 6 90 16 1* 2 2 2
7 19 5 87 14 1* 2 2 2
8 16 4 84 17.2 1 2 2 2
9 30 10 82 14.9 1 2 2 2
10 11 5 85 15.6 2 2 2 2
11 13 5 81 20.3 2 1 2 1
12 24 4 78 16.5 2 2 2 2
13 8 5 95 13.7 2 2 2 2
14 12 6 93 13 2 2 2 2
Asterisks indicate lungs with no perfusion of hepatic venous blood.
Hb 5 hemoglobin in g/dl; O2 Sat 5 oxygen saturation in aorta; PAP 5 mean pulmonary artery pressure; TPG 5
transpulmonary gradient in mm Hg (difference between mean pulmonary artery pressure and mean left atrial pressure or
pulmonary wedge pressure).
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periodic assessment. Contrast echocardiography can be
used as a sensitive screening tool for detecting PAVM in
patients with CPA. If screening contrast echocardio-
graphic study is positive, selective angiography of both
branch pulmonary arteries should be performed and
examined carefully for PAVM. Because of its safety, ease
of use and wide availability, bubble contrast echocardi-
ography can also be used routinely during follow-up
cardiac catheterization of patients who have initial neg-
ative angiograms for PAVM.
Hepatic factor. Pulmonary arteriovenous malformation is
a known complication of patients with liver disease (8).
Srivastava et al. reported a series of 10 patients with PAVM
and found a common anatomic feature of exclusion of
hepatic venous blood from pulmonary circulation (7).
Therefore, the authors inferred that the development of
PAVM after CPA is related to the diversion of normal
hepatic venous flow from the pulmonary circulation. In the
present study, we found all lungs with no hepatic venous
blood to pulmonary circulation had positive contrast echo-
cardiographic studies. There was significant difference in
PAVM between lungs with hepatic venous flow to pulmo-
nary circulation and lungs without hepatic venous flow to
pulmonary circulation. Interestingly, two of the three pa-
tients with hepatic venous blood to pulmonary circulation
who had positive contrast echocardiograms showed prefer-
ential streaming of inferior vena cava and hepatic venous
flow away from the lungs where positive studies were
obtained. In addition, patients with unidirectional Fontan
operation (that diverts inferior vena cava and hepatic veins
to the right pulmonary artery) had bubble contrast returned
only from selective left pulmonary artery injection but not in
selective right pulmonary artery injections. These findings
are consistent with our previous experience and also with
observations by others (20,23). Whether the so-called “he-
patic factor” exists or not remains an unsolved problem.
Results of the present study are strongly suggestive that lack
of hepatic venous blood is a major contributing factor to the
development of PAVM in patients after CPA. In addition,
patients with CPA who have additional sources of pulmo-
nary flow may also develop PAVM if streaming of hepatic
venous return away from one lung is present. On the basis
of our findings, we recommend that patients with no
hepatic venous blood to the pulmonary circulation after
CPA should receive careful examination of both lungs with
contrast echocardiograms performed during subsequent car-
diac catheterization.
Additional sources of pulmonary flow. Many centers are
now performing bidirectional Glenn shunt as an interme-
diate stage of palliation with very low mortality and mor-
bidity for young infants having functional single ventricle
(24–26). Surgical strategy regarding additional sources of
pulmonary flow for patients undergoing bidirectional Glenn
shunt is debatable (27,28). Advocates for additional sources
of pulmonary flow argue that pulmonary vascular compli-
cations, such as development of venovenous collateral ves-
sels and poor growth of pulmonary vasculature, may result
from the lack of additional sources of pulmonary blood flow
(29). In the present study, we found that all lungs with no
hepatic venous blood perfusion had positive contrast echo-
cardiograms. Therefore, we believe that additional sources
of pulmonary flow that include hepatic venous blood are
advantageous in reducing the late complication of PAVM
development.
Study limitations. This study has important limitations.
We have demonstrated the usefulness of bubble contrast
echocardiography in detecting angiographically negative
PAVM. Bubble contrast echocardiography is safe and easy
to perform during cardiac catheterization. In addition, the
results can be recorded and analyzed semiquantitatively by
comparing the amount of contrast return to the heart in a
standard echocardiographic view. Therefore, contrast echo-
cardiography offers an excellent tool for periodic follow-up
assessment of patients after CPA. In this study, we did not
attempt to quantify the amount of bubble contrast, and no
follow-up comparison of the same patients over time was
conducted. Further studies are needed to evaluate the
correlation among clinical course, development of PAVM
and contrast echocardiographic findings in patients with
CPA over time.
One limitation of the applicability of this study protocol
in clinical use is the need for selective pulmonary artery
injections which can only be performed during cardiac
catheterization. If contrast echocardiography is performed
by injecting agitated saline solution to a peripheral vein of
the upper extremity or neck in patients with Glenn shunt,
the interpretation of results may be difficult due to 1) poor
localization of bubble contrast return from left or right lung;
or 2) positive study from other forms of abnormal connec-
tions such as systemic venovenous collaterals.
Conclusions. Bubble contrast echocardiography, com-
pared with the traditional method of pulmonary angiogra-
phy, is a more sensitive tool in detecting early development
of PAVM in patients with CPA. The prevalence of PAVM
in patients with CPA, measured by contrast echocardiog-
raphy, may be much higher than what had been reported
previously by using angiography. Lungs with no perfusion
of hepatic venous blood are more likely to develop PAVM
than lungs with hepatic venous blood flow. We recommend
that children with CPA and unexplained desaturation
should have screening and periodic follow-up bubble con-
trast echocardiograms.
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